A Study of the Safety and Effectiveness of Oral Levofloxacin Compared With Cefuroxime Axetil in the Treatment of Adults With Persistent Bronchitis Experiencing Rapid Onset of Severe Worsening of Symptoms Caused by Bacteria

PHASE3CompletedINTERVENTIONAL

Enrollment

485

Participants

Timeline

Start Date

August 31, 1993

Study Completion Date

May 31, 1994

Conditions

Bronchitis, Chronic

Interventions

DRUG

levofloxacin

All Listed Sponsors

collaborator

PriCara, Unit of Ortho-McNeil, Inc.

INDUSTRY

lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY